Allena Pharmaceuticals Announces $25 Million Strategic Convertible Debt Financing Agreement with Pontifax Ventures
— Extends Allena’s Cash Runway into 4Q 2021 —— Debt Can be Converted into Equity at a Price of $4.10 […]
CHF Solutions Initiatives at HFSA 24th Annual Scientific Meeting Highlight Aquadex Therapy Performance in Heart Failure
EDEN PRAIRIE, Minn., Sept. 30, 2020 (GLOBE NEWSWIRE) — CHF Solutions (Nasdaq: CHFS), a medical device company dedicated to changing […]
Fate Therapeutics to Present at Jefferies Cell Therapy Virtual Summit
SAN DIEGO, Sept. 30, 2020 (GLOBE NEWSWIRE) — Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to the development of […]
Verisk and Duck Creek Announce the Addition of Verisk’s BuildFax Solutions to the Duck Creek Platform
Jersey City, N.J., Sept. 30, 2020 (GLOBE NEWSWIRE) — Verisk (Nasdaq:VRSK), a leading data analytics provider, and Duck Creek Technologies, […]
Fulgent Genetics Announces Partnership with Ohio Department of Rehabilitation and Correction for COVID-19 Testing
TEMPLE CITY, Calif., Sept. 30, 2020 (GLOBE NEWSWIRE) — Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”), a […]
Shift Adds Automotive Retail Veteran Mark McCollum as CRO to Fuel Next Stage of Growth
SAN FRANCISCO, Sept. 30, 2020 (GLOBE NEWSWIRE) — Shift, a leading end-to-end auto ecommerce platform transforming the used car industry […]
Liquid Partners With Polycade to Release Retro Gaming Titles
VANCOUVER, British Columbia, Sept. 30, 2020 (GLOBE NEWSWIRE) — Liquid Media Group Ltd. (the “Company”, “Liquid Media” or “Liquid”) (Nasdaq: […]
Harrow Health Appoints Larry Van Horn to its Board of Directors
NASHVILLE, Tenn., Sept. 30, 2020 (GLOBE NEWSWIRE) — Harrow Health, Inc. (NASDAQ: HROW) today announced the appointment of Larry Van […]
EXL Health Named ‘One of the Strongest Performers in the Risk Adjustment & Analytics Space’ in 2020 KLAS Performance Report
NEW YORK, Sept. 30, 2020 (GLOBE NEWSWIRE) — EXL [NASDAQ: EXLS], a leading Operations Management and Analytics company, today announced […]
Ovid Therapeutics Provides Soticlestat (OV935/TAK-935) Results from ARCADE and ENDYMION Studies Showing Seizure Reduction in Rare Epilepsies
Results from signal-finding, pilot Phase 2 open-label ARCADE study and ENDYMION long-term extension study in CDKL5 deficiency disorder (CDD) and […]
